Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-06291874 in T2DM inadequately controlled on metformin
NCT02554877Phase 2Completed
- Sponsor
- Pfizer
- Start
- Oct 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of PF-06291874 in type 2 diabetes mellitus (T2DM), sponsored by Pfizer. Started Oct 2015; status: completed.
02
Drugs
PF-06291874
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02554877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02554877.